☰

Merritt Roe Smith

Affiliations: 
Massachusetts Institute of Technology, Cambridge, MA, United States 
Google:
"Merritt Smith"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Philip Klein grad student 1971 Penn State
 ("The Harpers Ferry Armory and the New Technology in America, 1794-1854")
Hugo Meier grad student 1971 Penn State
 ("The Harpers Ferry Armory and the New Technology in America, 1794-1854")

Children

Sign in to add trainee
Lindy B. Biggs grad student 1987 MIT (PoliSci Tree)
Colleen A. Dunlavy grad student 1988 MIT (PoliSci Tree)
Brian O'Donnell grad student 1995 MIT
David Mindell grad student 1996 MIT
Gregory Clancey grad student 1999 MIT
Linda Endersby grad student 1999 MIT
Greg Galer grad student 2001 MIT
Robert Martello grad student 2001 MIT
Benjamin Pinney grad student 2001 MIT
David Luckso grad student 2005 MIT
Jamie Pietruska grad student 2009 MIT
Rebecca Perry grad student 2014 MIT
Renee Blackburn grad student 2017 MIT

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vogl UM, Beer TM, Davis ID, et al. (2021) Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings. European Journal of Cancer (Oxford, England : 1990)
Oudard S, Hadaschik B, Saad F, et al. (2021) Health-related Quality of Life at the SPARTAN Final Analysis of Apalutamide for Nonmetastatic Castration-resistant Prostate Cancer Patients Receiving Androgen Deprivation Therapy. European Urology Focus
Smith MR, Shore N, Tammela TL, et al. (2021) Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial. European Journal of Cancer (Oxford, England : 1990). 154: 138-146
Smith MR, Thomas S, Gormley M, et al. (2021) Blood Biomarker Landscape in Patients with High-Risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Feng FY, Thomas S, Saad F, et al. (2021) Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer. Jama Oncology
Agarwal N, Oudard S, Piulats JM, et al. (2021) CYCLONE 1: A phase 2 study of abemaciclib in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a novel hormonal agent and taxane-based chemotherapy. Journal of Clinical Oncology. 39: TPS5086-TPS5086
Chi KN, Saad F, Chowdhury S, et al. (2021) PD34-11 PROSTATE-SPECIFIC ANTIGEN KINETICS IN PATIENTS WITH ADVANCED PROSTATE CANCER TREATED WITH APALUTAMIDE: RESULTS FROM THE TITAN AND SPARTAN STUDIES Journal of Urology. 206
Shen J, Chowdhury S, Agarwal N, et al. (2021) 618P Apalutamide (APA) for advanced prostate cancer in older patients (pts): Combined analysis of TITAN & SPARTAN Annals of Oncology. 32: S656-S657
Uemura H, Satoh T, Tsumura H, et al. (2020) Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 study. Prostate International. 8: 190-197
Uemura H, Matsushima H, Kobayashi K, et al. (2020) Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial. International Journal of Clinical Oncology
See more...